Donor Cell–Derived Leukemias/Myelodysplastic Neoplasms in Allogeneic Hematopoietic Stem Cell Transplant Recipients-Reference-Cited by-同舟云学术

Donor Cell–Derived Leukemias/Myelodysplastic Neoplasms in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Published:2011-04 Issue:4 Volume:135 Page:525-540
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Wang Endi,Hutchinson Charles Blake,Huang Qin,Lu Chuanyi Mark,Crow Jennifer,Wang Frances F.,Sebastian Siby,Rehder Catherine,Lagoo Anand,Horwitz Mitchell,Rizzieri David,Yu Jingwei,Goodman Barbara,Datto Michael,Buckley Patrick

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/135/4/525/4989606/ajcpath135-0525.pdf

Reference81 articles.

1. Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

2. Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation

5. Witherspoon RP Schubach W Neiman P Donor cell leukemia developing six years after marrow grafting for acute leukemia. Blood. 1985;65:1172–1174.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations—Brief Report;Current Oncology;2024-04-05

2. Cross‐individual cancer transmission to children during the gestational and perinatal periods;Cancer Science;2024-02-18

3. Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation;Transplantation and Cellular Therapy;2023-10

4. Case report: Rare case of donor cell‐derived T‐cell acute lymphoblastic leukaemia in a female patient after receiving an allo‐transplant from her male sibling;British Journal of Haematology;2023-07-31

5. Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials;Transplantation and Cellular Therapy;2023-05